Physician profile
Aaron Weber
NPI 1164758470
$8,880.25
in general payments reported to CMS, 2019-2025
11 companies · $899 in 2025
The $899 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,506 · 2021: $33.49 · 2022: $5,700 · 2023: $295 · 2024: $446 · 2025: $899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,640.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,498.46 | 2020-2022 | |
| Titan Surgical Group, LLC | $1,831.54 | 2022-2025 | |
| Anika Therapeutics, INC. | $1,031.71 | 2022 | |
| Elite Orthopedics, LLC | $963.90 | 2020 | |
| Stryker Corporation | $777.99 | 2023-2025 | Mako, Insignia, Triathlon |
| Acumed LLC | $498.21 | 2022-2025 | Acumed, Inframe Implant, Osteomed |
| Becton, Dickinson and Company | $155.45 | 2025 | Arista |
| Alafair Biosciences, INC. | $34.79 | 2022 | |
| Axogen | $33.49 | 2021 | |
| Polynovo North America LLC | $30.22 | 2024 | Novosorb Btm |
| Organogenesis INC. | $24.49 | 2025 | Puraply Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.